To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)
Public ClinicalTrials.gov record NCT00754065. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Group, 2-arm Study to Show Superiority of the Oral Contraceptive SH T00658ID Over Ortho Tri-Cyclen Lo on Hormone Withdrawal-associated Symptoms After 6 Cycles of Treatment.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to compare the oral contraceptive (OC) SH T00658ID over Ortho Tri-Cyclen Lo administered for 13 cycles to healthy female volunteers between 18 and 50 years of age who request oral contraceptive protection. Subjects on a levonorgestrel (LNG), norgestimate (NGM), norethindrone or norethindrone acetate containing oral contraceptive in a 21-day regimen suffering from hormone withdrawal-associated symptoms such as pelvic pain or headache or both, and willing to continue OC use but to switch to SH T00658ID or Ortho Tri-Cyclen Lo.
Study identification
- NCT ID
- NCT00754065
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 409 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 8, 2008 (Actual)
- Primary completion
- May 10, 2011 (Actual)
- Completion
- May 10, 2011 (Actual)
- Last update posted
- Nov 20, 2024
2008 – 2011
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Independence | Arizona | 94925 | — |
| Not listed | Phoenix | Arizona | 85032 | — |
| Not listed | Encinitas | California | 92024 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | Santa Monica | California | 90404 | — |
| Not listed | Denver | Colorado | 80206 | — |
| Not listed | Denver | Colorado | 80218 | — |
| Not listed | Littleton | Colorado | 80127 | — |
| Not listed | Clearwater | Florida | 33759 | — |
| Not listed | Jacksonville | Florida | 32207 | — |
| Not listed | West Palm Beach | Florida | 33409 | — |
| Not listed | Decatur | Georgia | 30034 | — |
| Not listed | Boise | Idaho | 83702 | — |
| Not listed | Boise | Idaho | 83712 | — |
| Not listed | Idaho Falls | Idaho | 83406 | — |
| Not listed | Fishers | Indiana | 46037 | — |
| Not listed | Indianapolis | Indiana | 46217 | — |
| Not listed | South Bend | Indiana | 46601 | — |
| Not listed | Metairie | Louisiana | 70006 | — |
| Not listed | Chesterfield | Missouri | 63017 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Lincoln | Nebraska | 68510 | — |
| Not listed | Las Vegas | Nevada | 89128 | — |
| Not listed | New Brunswick | New Jersey | 08901 | — |
| Not listed | Winston-Salem | North Carolina | 94925 | — |
| Not listed | Cincinnati | Ohio | 45246 | — |
| Not listed | Columbus | Ohio | 43213 | — |
| Not listed | Portland | Oregon | 97239-3011 | — |
| Not listed | Philadelphia | Pennsylvania | 19114 | — |
| Not listed | Bristol | Tennessee | 37620 | — |
| Not listed | Memphis | Tennessee | 38120 | — |
| Not listed | Houston | Texas | 77054 | — |
| Not listed | Spokane | Washington | 99207 | — |
| Not listed | La Crosse | Wisconsin | 54601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00754065, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00754065 live on ClinicalTrials.gov.